CKD Bio Corp. (063160.KS) KSC

23,650.00

-50(-0.21%)

Updated at September 09 02:37PM

Currency In KRW

Valuation

Market Cap120.69B
Enterprise Value250.8B
P/E Ratio69.23
PEG Ratio-0.96
Price/Sales Ratio0.82
Price/Book Ratio1
Enterprise/Revenue1.67
Enterprise/EBITDA16.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.05

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue171.76B
Revenue/Share28,826.25
Gross Profit35.94B
EBITDA31.17B
Net Income8.7B
Diluted EPS1,586.02

Balance Sheet

Total Cash1.48B
Total Cash/Share268.13
Total Debt136.91B
Total Debt/Equity1.05
Current Ratio1.26
Book Value Per Share23,718.77

Price History

52-Week Change-21.04
52-Week High32,150
52-Week Low19,710
Moving Average 50 Days23,120
Moving Average 200 Days22,336

Statistics

Average Volume43,390
Shares Outstanding5.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate100
Trailing Annual Dividend Yield0.42
Payout Ratio0
Last Split Factor21:20
Last Split DateDecember 27, 2019